Primecap Management Co. CA Lowers Stake in Humana Inc. (NYSE:HUM)

Primecap Management Co. CA lowered its holdings in Humana Inc. (NYSE:HUM - Free Report) by 48.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,376 shares of the insurance provider's stock after selling 18,119 shares during the quarter. Primecap Management Co. CA's holdings in Humana were worth $4,916,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HUM. FPC Investment Advisory Inc. acquired a new stake in Humana during the 4th quarter worth about $27,000. Centricity Wealth Management LLC purchased a new stake in shares of Humana in the fourth quarter worth about $30,000. LFA Lugano Financial Advisors SA raised its position in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in Humana in the fourth quarter valued at approximately $33,000. Finally, Atwood & Palmer Inc. boosted its position in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HUM. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley reduced their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Barclays lifted their target price on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 13th. Finally, Truist Financial increased their target price on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. Eighteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Humana presently has an average rating of "Hold" and a consensus price target of $285.68.

Remove Ads

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.37% of the company's stock.

Humana Stock Up 2.1 %

HUM traded up $5.48 on Monday, reaching $271.65. The company's stock had a trading volume of 1,252,836 shares, compared to its average volume of 1,714,263. The company has a market capitalization of $32.79 billion, a price-to-earnings ratio of 27.30, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a 50 day moving average of $271.33 and a two-hundred day moving average of $276.25.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.